Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
- PMID: 15747069
- DOI: 10.1007/s10350-004-0900-9
Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
Abstract
Purpose: Local excision for early-staged rectal cancers is controversial. Preoperative understaging is not uncommon and radical resection after local resection may be needed for a curative treatment. The aim of this study was to determine the frequency and outcome of radical resection (within 30 days) after local excision for rectal adenocarcinoma.
Methods: All locally excised rectal cancers (curative intent) that required radical surgery within 30 days were reviewed (1980-2000). T2-3N0-1 stage cancers were each matched to three primary radical surgery controls for stage, age (+/- 5 years), gender, date (+/- 1 years), and type (abdominoperineal resection or low anterior resection) of operation. T1N0-1 cancers were compared with stage-matched rectal cancers treated by either primary radical surgery (n = 78) or local excision alone (n = 77).
Results: Fifty-two locally excised rectal adenocarcinomas (29 transanal and 23 polypectomies) were followed by radical surgery (24 abdominoperineal resection and 28 low anterior resection) within 7 (range, 1-29) days. Radical surgery was performed because of a cancerous polyp (n = 42), positive margins (5), lymphovascular invasion (3), and T3-staged cancer (2). Twelve of 52 cancers (23 percent) were found to have nodal involvement and 15 of 52 (29 percent) showed residual cancer in the resected specimen. The T2-3N0-1 stage controls were well matched. No significant difference in tumor location, size, adjuvant therapy, or length of follow-up was noted. Local and distant recurrence occurred in 2 of 4 T2-3N1 tumors and in 2 of 11 T2-3N0 cancers and were comparable to the matched controls, as was survival, with the exception of shorter survival in T3N1 cases, but numbers were too small for a definitive conclusion. Length of follow-up was not different. For T1 cancers, the controls were also comparable regarding patient and tumor demographics and adjuvant therapy. Nodal involvement was 21 percent in T1 study cases and 15 percent in T1 primary radical-surgery controls, with a trend toward location in the lower third of the rectum in both groups (58 percent and 50 percent, respectively). Local recurrence rates were 3 percent in the study group, 5 percent for patients undergoing primary radical surgery, and 8 percent for local excision alone. Distant metastasis (11 percent, 12 percent, and 13 percent, respectively) and overall five-year survival were also not significantly different (78 percent, 89 percent, and 73 percent, respectively).
Conclusions: Nodal involvement in attempted locally excised rectal cancers is not uncommon. Local excision of rectal tumors followed by radical surgery within 30 days in cancer patients does not compromise outcome compared with primary radical surgery. Even after radical surgery for superficial T1 rectal cancers, recurrence rates are not insignificant. Future improvements in preoperative staging may be helpful in selecting tumors for local excision only.
Similar articles
-
Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.Dis Colon Rectum. 2004 Jan;47(1):48-58. doi: 10.1007/s10350-003-0012-y. Epub 2004 Jan 14. Dis Colon Rectum. 2004. PMID: 14719151
-
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16414206 Clinical Trial.
-
Recurrence after transanal excision of T1 rectal cancer: should we be concerned?Dis Colon Rectum. 2005 Apr;48(4):711-9; discussion 719-21. doi: 10.1007/s10350-004-0666-0. Dis Colon Rectum. 2005. PMID: 15768186
-
Early rectal cancer: local excision or radical surgery?J Surg Educ. 2008 Jan-Feb;65(1):67-72. doi: 10.1016/j.jsurg.2007.11.002. J Surg Educ. 2008. PMID: 18308284 Review.
-
Management of early rectal T1 and T2 cancers.Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6885s-9s. doi: 10.1158/1078-0432.CCR-07-1150. Clin Cancer Res. 2007. PMID: 18006794 Review.
Cited by
-
Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection.World J Gastroenterol. 2022 Aug 14;28(30):4019-4043. doi: 10.3748/wjg.v28.i30.4019. World J Gastroenterol. 2022. PMID: 36157105 Free PMC article. Review.
-
Local excision for ypT2 rectal cancer--much ado about something.J Gastrointest Surg. 2007 Nov;11(11):1431-8; discussion 1438-40. doi: 10.1007/s11605-007-0271-3. Epub 2007 Sep 6. J Gastrointest Surg. 2007. PMID: 17805938
-
Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy.World J Gastroenterol. 2007 Jan 28;13(4):515-24. doi: 10.3748/wjg.v13.i4.524. World J Gastroenterol. 2007. PMID: 17278216 Free PMC article.
-
Multidisciplinary treatment of rectal cancer in 2014: where are we going?World J Gastroenterol. 2014 Aug 28;20(32):11249-61. doi: 10.3748/wjg.v20.i32.11249. World J Gastroenterol. 2014. PMID: 25170209 Free PMC article. Review.
-
Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy.J Gastrointest Surg. 2006 Dec;10(10):1319-28; discussion 1328-9. doi: 10.1016/j.gassur.2006.09.005. J Gastrointest Surg. 2006. PMID: 17175450
MeSH terms
LinkOut - more resources
Full Text Sources